fda glp-1 compounding warning october 2025 New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages FDA warns against compounded GLP-1

If you take insulin, talk to your doctor or nutritionist to learn how to properly dose for it

Visceral fat is strongly associated with cardiovascular disease, type 2 diabetes, and certain cancers

Fracture Risk Data from GLP1 Trials Several cardiovascular outcomes trials (CVOTs) have collected fracture data as secondary outcomes: Trials involving semaglutide and dulaglutide generally report fracture rates similar to placebo A few studies suggest a potential increase in non-vertebral fractures, though findings are inconsistent and often not statistically significant One important confounder is weight loss, which itself can lead to bone loss

2003;285(3):C698-710

Randal was exceptionally h